![Differential association of fluconazole dose and dose/MIC ratio with mortality in patients with Candida albicans and non-albicans bloodstream infection - ScienceDirect Differential association of fluconazole dose and dose/MIC ratio with mortality in patients with Candida albicans and non-albicans bloodstream infection - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1198743X15007211-gr3.jpg)
Differential association of fluconazole dose and dose/MIC ratio with mortality in patients with Candida albicans and non-albicans bloodstream infection - ScienceDirect
![Fluconazole resistance in Candida albicans is induced by Pseudomonas aeruginosa quorum sensing | Scientific Reports Fluconazole resistance in Candida albicans is induced by Pseudomonas aeruginosa quorum sensing | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-64761-3/MediaObjects/41598_2020_64761_Fig1_HTML.png)
Fluconazole resistance in Candida albicans is induced by Pseudomonas aeruginosa quorum sensing | Scientific Reports
![JoF | Free Full-Text | Comparison of Two Commercial Colorimetric Broth Microdilution Tests for Candida Susceptibility Testing: Sensititre YeastOne versus MICRONAUT-AM JoF | Free Full-Text | Comparison of Two Commercial Colorimetric Broth Microdilution Tests for Candida Susceptibility Testing: Sensititre YeastOne versus MICRONAUT-AM](https://www.mdpi.com/jof/jof-07-00356/article_deploy/html/images/jof-07-00356-g001a.png)
JoF | Free Full-Text | Comparison of Two Commercial Colorimetric Broth Microdilution Tests for Candida Susceptibility Testing: Sensititre YeastOne versus MICRONAUT-AM
![Breakpoints for Susceptibility Testing Should Not Divide Wild-Type Distributions of Important Target Species | Antimicrobial Agents and Chemotherapy Breakpoints for Susceptibility Testing Should Not Divide Wild-Type Distributions of Important Target Species | Antimicrobial Agents and Chemotherapy](https://journals.asm.org/cms/10.1128/aac.01624-08/asset/b541ed67-d6b6-479a-9224-e5483309279f/assets/graphic/zac0040980070001.jpeg)
Breakpoints for Susceptibility Testing Should Not Divide Wild-Type Distributions of Important Target Species | Antimicrobial Agents and Chemotherapy
![Table 4 from Isolation and characterization of Candida spp. in Jordanian cancer patients: prevalence, pathogenic determinants, and antifungal sensitivity. | Semantic Scholar Table 4 from Isolation and characterization of Candida spp. in Jordanian cancer patients: prevalence, pathogenic determinants, and antifungal sensitivity. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/53b1e5f13a949141a4581f70a38f8063b9bf8745/4-Table4-1.png)
Table 4 from Isolation and characterization of Candida spp. in Jordanian cancer patients: prevalence, pathogenic determinants, and antifungal sensitivity. | Semantic Scholar
Antifungal Susceptibility of Non-albicans Candida Species in A Tertiary Care Hospital, Bulgaria | Jundishapur Journal of Microbiology | Full Text
![Investigation of fluconazole susceptibility to Candida albicans by MALDI-TOF MS and real-time PCR for CDR1, CDR2, MDR1 and ERG11 | BMC Microbiology | Full Text Investigation of fluconazole susceptibility to Candida albicans by MALDI-TOF MS and real-time PCR for CDR1, CDR2, MDR1 and ERG11 | BMC Microbiology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12866-022-02564-4/MediaObjects/12866_2022_2564_Fig2_HTML.png)
Investigation of fluconazole susceptibility to Candida albicans by MALDI-TOF MS and real-time PCR for CDR1, CDR2, MDR1 and ERG11 | BMC Microbiology | Full Text
In Vitro and In Vivo Antifungal Activity of Lichochalcone-A against Candida albicans Biofilms | PLOS ONE
![Investigation of fluconazole susceptibility to Candida albicans by MALDI-TOF MS and real-time PCR for CDR1, CDR2, MDR1 and ERG11 | BMC Microbiology | Full Text Investigation of fluconazole susceptibility to Candida albicans by MALDI-TOF MS and real-time PCR for CDR1, CDR2, MDR1 and ERG11 | BMC Microbiology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12866-022-02564-4/MediaObjects/12866_2022_2564_Fig1_HTML.png)
Investigation of fluconazole susceptibility to Candida albicans by MALDI-TOF MS and real-time PCR for CDR1, CDR2, MDR1 and ERG11 | BMC Microbiology | Full Text
![Differential association of fluconazole dose and dose/MIC ratio with mortality in patients with Candida albicans and non-albicans bloodstream infection - ScienceDirect Differential association of fluconazole dose and dose/MIC ratio with mortality in patients with Candida albicans and non-albicans bloodstream infection - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1198743X15007211-gr2.jpg)
Differential association of fluconazole dose and dose/MIC ratio with mortality in patients with Candida albicans and non-albicans bloodstream infection - ScienceDirect
Minimum inhibitory concentration (MIC) of fluconazole and miconazole... | Download Scientific Diagram
![PDF] Evaluation of Spectrophotometric Broth Microdilution Method to Determine the Fluconazole MIC of the Candida Species | Semantic Scholar PDF] Evaluation of Spectrophotometric Broth Microdilution Method to Determine the Fluconazole MIC of the Candida Species | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/639b19689c70088661a6f2e896ddd6215ed54c08/3-Table1-1.png)
PDF] Evaluation of Spectrophotometric Broth Microdilution Method to Determine the Fluconazole MIC of the Candida Species | Semantic Scholar
![Impact of high MIC of fluconazole on outcomes of Candida glabrata bloodstream infection: a retrospective multicenter cohort study - ScienceDirect Impact of high MIC of fluconazole on outcomes of Candida glabrata bloodstream infection: a retrospective multicenter cohort study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0732889318301457-gr1.jpg)